These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension. Austin MJ; McDougall NI; Wendon JA; Sizer E; Knisely AS; Rela M; Wilson C; Callender ME; O'Grady JG; Heneghan MA Liver Transpl; 2008 Mar; 14(3):287-91. PubMed ID: 18306330 [TBL] [Abstract][Full Text] [Related]
44. Acute hemodynamic effects of single-dose sildenafil when added to established bosentan therapy in patients with pulmonary arterial hypertension: results of the COMPASS-1 study. Gruenig E; Michelakis E; Vachiéry JL; Vizza CD; Meyer FJ; Doelberg M; Bach D; Dingemanse J; Galiè N J Clin Pharmacol; 2009 Nov; 49(11):1343-52. PubMed ID: 19755415 [TBL] [Abstract][Full Text] [Related]
50. Long-term outcome with intravenous iloprost in pulmonary arterial hypertension. Hoeper MM; Gall H; Seyfarth HJ; Halank M; Ghofrani HA; Winkler J; Golpon H; Olsson KM; Nickel N; Opitz C; Ewert R Eur Respir J; 2009 Jul; 34(1):132-7. PubMed ID: 19251782 [TBL] [Abstract][Full Text] [Related]
51. Treatment of pulmonary arterial hypertension. Humbert M; Sitbon O; Simonneau G N Engl J Med; 2004 Sep; 351(14):1425-36. PubMed ID: 15459304 [No Abstract] [Full Text] [Related]
52. [Combination therapy for the treatment of pulmonary arterial hypertension]. Kähler CM Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S181-2. PubMed ID: 19718614 [No Abstract] [Full Text] [Related]
53. Efficacy of sildenafil as a rescue therapy for patients with severe pulmonary arterial hypertension and given long-term treatment with prostanoids: 2-year experience. Ruiz MJ; Escribano P; Delgado JF; Jiménez C; Tello R; Gómez MA; de la Calzada CS J Heart Lung Transplant; 2006 Nov; 25(11):1353-7. PubMed ID: 17097500 [TBL] [Abstract][Full Text] [Related]
54. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results]. Jiménez López-Guarch C; Escribano Subias P; Tello de Meneses R; Delgado Jiménez JF; Sadia Pérez D; Velázquez Martín MT; Gómez Sánchez MA; Sáenz de la Calzada C Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792 [TBL] [Abstract][Full Text] [Related]
55. Usefulness of first-line combination therapy with epoprostenol and bosentan in pulmonary arterial hypertension: an observational study. Kemp K; Savale L; O'Callaghan DS; Jaïs X; Montani D; Humbert M; Simonneau G; Sitbon O J Heart Lung Transplant; 2012 Feb; 31(2):150-8. PubMed ID: 22138355 [TBL] [Abstract][Full Text] [Related]
57. Continuous intravenous iloprost to revert treatment failure of first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension. Ewert R; Opitz CF; Wensel R; Winkler J; Halank M; Felix SB Clin Res Cardiol; 2007 Apr; 96(4):211-7. PubMed ID: 17294349 [TBL] [Abstract][Full Text] [Related]
58. Severe pulmonary arterial hypertension secondary to lupus in the emergency department: proactive intense care associated with a better short-term survival. Chen Y; Guo L; Li Y; Chen GL; Chen XX; Ye S Int J Rheum Dis; 2015 Mar; 18(3):331-5. PubMed ID: 24946184 [TBL] [Abstract][Full Text] [Related]